Torrent Pharma Shares in Focus After Steady Q3; Street Positive on JB Merger Benefits
Torrent Pharmaceuticals has emerged as a key talking point in the Indian equity markets after reporting a steady Q3 performance and receiving strong endorsements from analysts regarding the benefits of its merger with JB Chemicals. The company’s financial resilience, coupled with strategic expansion through mergers and acquisitions, has positioned it favorably in the pharmaceutical sector….